ArticleTherapeutic advances in endocrinology and metabolism2026
Clinical significance of meteorin-like protein in type 2 diabetes mellitus and its association with carotid plaque complications.
Article in Therapeutic advances in endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metrnl and macrophage polarization: role in skeletal muscle homeostasis and therapeutic potential.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atherosclerosis (AS) is an important risk factor for macrovascular complications in diabetes mellitus and also serves as an independent risk factor for adverse cardiovascular and cerebrovascular events. Objectives: This study aims to investigate the association between serum meteorin-like protein (Metrnl) levels and carotid artery plaques in patients with type 2 diabetes mellitus (T2DM). Design: This study is a cross-sectional study that recruited patients with type 2 diabetes from our hospital's endocrinology department and healthy subjects from the physical examination center. Carotid ultrasound and glucose tolerance test were performed, and subjects were grouped and analyzed based on the results of the carotid ultrasound and glucose tolerance test. Methods: A total of 208 participants were enrolled in this study. Serum Metrnl concentrations were measured using an enzyme-linked immunosorbent assay. The predictive value of Metrnl for carotid plaque development in T2DM patients was evaluated using receiver operating characteristic (ROC) curve analysis. Results: Serum Metrnl levels were elevated in the T2DM with carotid plaque group compared to those without ( Conclusion: Elevated Metrnl levels are a risk factor for carotid plaque formation in T2DM patients, suggesting a potential role of Metrnl in the initiation and progression of carotid atherosclerosis in diabetic individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.